Correlation Between Inhibrx and 686330AN1
Specify exactly 2 symbols:
By analyzing existing cross correlation between Inhibrx and ORIX 225 09 MAR 31, you can compare the effects of market volatilities on Inhibrx and 686330AN1 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of 686330AN1. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and 686330AN1.
Diversification Opportunities for Inhibrx and 686330AN1
Average diversification
The 3 months correlation between Inhibrx and 686330AN1 is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and ORIX 225 09 MAR 31 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ORIX 225 09 and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with 686330AN1. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ORIX 225 09 has no effect on the direction of Inhibrx i.e., Inhibrx and 686330AN1 go up and down completely randomly.
Pair Corralation between Inhibrx and 686330AN1
Given the investment horizon of 90 days Inhibrx is expected to under-perform the 686330AN1. In addition to that, Inhibrx is 5.0 times more volatile than ORIX 225 09 MAR 31. It trades about -0.05 of its total potential returns per unit of risk. ORIX 225 09 MAR 31 is currently generating about -0.12 per unit of volatility. If you would invest 8,466 in ORIX 225 09 MAR 31 on September 1, 2024 and sell it today you would lose (97.00) from holding ORIX 225 09 MAR 31 or give up 1.15% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 66.67% |
| Values | Daily Returns |
Inhibrx vs. ORIX 225 09 MAR 31
Performance |
| Timeline |
| Inhibrx |
| ORIX 225 09 |
Inhibrx and 686330AN1 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and 686330AN1
The main advantage of trading using opposite Inhibrx and 686330AN1 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, 686330AN1 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 686330AN1 will offset losses from the drop in 686330AN1's long position.| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
| 686330AN1 vs. Q2 Holdings | 686330AN1 vs. NetSol Technologies | 686330AN1 vs. Inhibrx | 686330AN1 vs. Regeneron Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world |